The outlook revision reflects Moody’s Investors Service’s expectation that WFB will maintain its current margins and increase cash flow over the next year.
Moody’s also assigned an “A2” rating to WFB’s $151.7 million of series 2016 bonds.
The rating assignment is based on a number of factors, including WFB’s strengths as a large academic medical center with a solid clinical reputation, strong market share, and solid balance sheet.
More articles on healthcare finance:
Moody’s downgrades Fremont-Rideout Health Group’s rating to ‘Ba3’
19 recent hospital outlook and credit rating actions
ZirMed takes prize for RCM platform
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.